(INFY) Infosys - Overview
Stock: Consulting, Outsourcing, Digital, Cloud, AI
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.93% |
| Yield on Cost 5y | 3.37% |
| Yield CAGR 5y | 6.64% |
| Payout Consistency | 71.6% |
| Payout Ratio | 67.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 25.4% |
| Relative Tail Risk | -7.87% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.63 |
| Alpha | -29.83 |
| Character TTM | |
|---|---|
| Beta | 0.732 |
| Beta Downside | 0.788 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.08% |
| CAGR/Max DD | -0.01 |
Description: INFY Infosys January 27, 2026
Infosys Ltd (NYSE:INFY) is a global provider of consulting, technology, outsourcing, and digital transformation services, operating across North America, Europe, India, and other regions. Its portfolio spans digital marketing, AI (including generative AI), cloud, cybersecurity, enterprise applications (Oracle, SAP, Salesforce), and industry-specific platforms such as Finacle for banking and Topaz for AI-first solutions, serving a broad set of sectors from aerospace to retail.
Key recent metrics (FY 2024, released May 2024) show revenue of $16.3 billion, up 5 % YoY, with digital services contributing ≈ 38 % of total revenue and delivering a 30 % operating margin-about 4 percentage points higher than legacy services. The order backlog stood at $23 billion, indicating roughly 14 months of booked work at current run-rate. EPS was $6.70, and the company returned $2.5 billion to shareholders via dividends and share buybacks.
Macro-level drivers that could affect INFY’s outlook include: (1) US enterprise IT spend, projected to grow ≈ 6 % annually through 2026, supporting demand for cloud migration and AI services; (2) the Indian rupee’s relative weakness versus the dollar, which historically boosts offshore-delivery margins but adds cost-inflation risk for local hiring; and (3) the accelerating adoption of generative AI across industries, a segment where Infosys has launched the Topaz platform and is seeing double-digit revenue growth.
For a deeper, data-driven valuation framework, you may want to explore the detailed analyst models on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 3.21b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.24 > 0.02 and ΔFCF/TA -1.37 > 1.0 |
| NWC/Revenue: 22.18% < 20% (prev 28.44%; Δ -6.25% < -1%) |
| CFO/TA 0.26 > 3% & CFO 4.09b > Net Income 3.21b |
| Net Debt (-1.24b) to EBITDA (4.55b): -0.27 < 3 |
| Current Ratio: 1.79 > 1.5 & < 3 |
| Outstanding Shares: last quarter (4.12b) vs 12m ago -2.59% < -2% |
| Gross Margin: 29.99% > 18% (prev 0.30%; Δ 2968 % > 0.5%) |
| Asset Turnover: 123.1% > 50% (prev 117.3%; Δ 5.75% > 0%) |
| Interest Coverage Ratio: 72.60 > 6 (EBITDA TTM 4.55b / Interest Expense TTM 47.3m) |
Altman Z'' 6.23
| A: 0.28 (Total Current Assets 9.96b - Total Current Liabilities 5.56b) / Total Assets 15.95b |
| B: 0.48 (Retained Earnings 7.63b / Total Assets 15.95b) |
| C: 0.21 (EBIT TTM 3.43b / Avg Total Assets 16.12b) |
| D: 1.36 (Book Value of Equity 9.06b / Total Liabilities 6.67b) |
| Altman-Z'' Score: 6.23 = AAA |
Beneish M -3.06
| DSRI: 0.97 (Receivables 5.73b/5.68b, Revenue 19.84b/19.11b) |
| GMI: 1.01 (GM 29.99% / 30.29%) |
| AQI: 1.02 (AQ_t 0.24 / AQ_t-1 0.24) |
| SGI: 1.04 (Revenue 19.84b / 19.11b) |
| TATA: -0.06 (NI 3.21b - CFO 4.09b) / TA 15.95b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of INFY shares?
Over the past week, the price has changed by -5.23%, over one month by -3.14%, over three months by +7.13% and over the past year by -17.88%.
Is INFY a buy, sell or hold?
- StrongBuy: 4
- Buy: 2
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the INFY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 19.3 | 9.7% |
| Analysts Target Price | 19.3 | 9.7% |
| ValueRay Target Price | 18 | 2.2% |
INFY Fundamental Data Overview February 02, 2026
P/E Forward = 21.097
P/S = 3.5836
P/B = 7.7776
P/EG = 2.7773
Revenue TTM = 19.84b USD
EBIT TTM = 3.43b USD
EBITDA TTM = 4.55b USD
Long Term Debt = 646.0m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 332.1m USD (from shortTermDebt, last quarter)
Debt = 978.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.24b USD (from netDebt column, last quarter)
Enterprise Value = 69.12b USD (71.12b + Debt 978.6m - CCE 2.98b)
Interest Coverage Ratio = 72.60 (Ebit TTM 3.43b / Interest Expense TTM 47.3m)
EV/FCF = 18.18x (Enterprise Value 69.12b / FCF TTM 3.80b)
FCF Yield = 5.50% (FCF TTM 3.80b / Enterprise Value 69.12b)
FCF Margin = 19.16% (FCF TTM 3.80b / Revenue TTM 19.84b)
Net Margin = 16.16% (Net Income TTM 3.21b / Revenue TTM 19.84b)
Gross Margin = 29.99% ((Revenue TTM 19.84b - Cost of Revenue TTM 13.89b) / Revenue TTM)
Gross Margin QoQ = 28.22% (prev 30.73%)
Tobins Q-Ratio = 4.33 (Enterprise Value 69.12b / Total Assets 15.95b)
Interest Expense / Debt = 1.15% (Interest Expense 11.2m / Debt 978.6m)
Taxrate = 27.80% (287.7m / 1.03b)
NOPAT = 2.48b (EBIT 3.43b * (1 - 27.80%))
Current Ratio = 1.79 (Total Current Assets 9.96b / Total Current Liabilities 5.56b)
Debt / Equity = 0.11 (Debt 978.6m / totalStockholderEquity, last quarter 9.24b)
Debt / EBITDA = -0.27 (Net Debt -1.24b / EBITDA 4.55b)
Debt / FCF = -0.33 (Net Debt -1.24b / FCF TTM 3.80b)
Total Stockholder Equity = 10.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.89% (Net Income 3.21b / Total Assets 15.95b)
RoE = 29.72% (Net Income TTM 3.21b / Total Stockholder Equity 10.79b)
RoCE = 30.01% (EBIT 3.43b / Capital Employed (Equity 10.79b + L.T.Debt 646.0m))
RoIC = 22.97% (NOPAT 2.48b / Invested Capital 10.79b)
WACC = 8.50% (E(71.12b)/V(72.10b) * Re(8.61%) + D(978.6m)/V(72.10b) * Rd(1.15%) * (1-Tc(0.28)))
Discount Rate = 8.61% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.26%
[DCF Debug] Terminal Value 78.31% ; FCFF base≈3.92b ; Y1≈4.51b ; Y5≈6.33b
Fair Price DCF = 24.69 (EV 98.64b - Net Debt -1.24b = Equity 99.88b / Shares 4.05b; r=8.50% [WACC]; 5y FCF grow 17.65% → 2.90% )
EPS Correlation: 45.03 | EPS CAGR: 0.0% | SUE: -1.39 | # QB: 0
Revenue Correlation: 90.89 | Revenue CAGR: 4.78% | SUE: -0.81 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.21 | Chg30d=+0.001 | Revisions Net=+1 | Analysts=7
EPS next Year (2027-03-31): EPS=0.85 | Chg30d=+0.005 | Revisions Net=+8 | Growth EPS=+8.6% | Growth Revenue=+7.3%